Centre for Discovery Brain Sciences
Centre for Discovery Brain Sciences Transparent Logo

Dr Jill Fowler

The goal of my research is to understand the mechanisms by which stroke and head injury cause degenerative changes in the brain which can can lead to dementia.

Dr Jill Fowler

Alzheimer’s Research UK Senior Research Fellow

  • The Chancellor's Building
  • 49 Little France Crescent
  • Edinburgh EH16 4SB

Contact details

Personal profile

Alzheimer’s Research UK Senior Research Fellow, University of Edinburgh 2015-present

Alzheimer’s Society Research Fellow, University of Edinburgh 2006-2015

Postdoctoral Research Fellow, Division of Neuroscience, University of Edinburgh 2003-2006

PhD (MRC-funded Industrial collaborative PhD in Neuroscience) University of Glasgow 2003

BSc (Neuroscience with First class Honours) University of Glasgow, 1999

Research Theme

Research

Brain injury, including that due to stroke and head injury, is associated with an increased risk of  cognitive deficits and dementia. The goal of my research is to understand the mechanisms by which stroke and head injury cause degenerative changes in the brain which can can lead to dementia.

In 2006, I was awarded a research fellowship by the Alzheimer’s Society to examine the mechanisms by which head injury can lead to Alzheimer’s Disease. I established a model of mild traumatic brain injury in mice which causes cognitive deficits and axonal pathology.  We are currently investigating novel proteins and pathways that are altered in response to mild head injury using a proteomic approach. 

In 2015, I was awarded a senior research fellowship by Alzheimer’s Research UK to understand how stroke can lead to dementia.  We are interested in a protective signalling pathway called Nrf2, which becomes activated when the cell encounters oxidative stress, and can switch on over 200 anti-inflammatory and anti-oxidant genes.  We are investigating how stroke alters Nrf2 signalling, and determining if manipulating nrf2 signalling with transgenic or pharmacological approaches can reduce neurodegeneration.

The ultimate goal of our research is to understand the pathological mechanisms that can lead to cognitive decline in dementia, with the aim of developing novel therapeutic approaches.

Team members

Funding

ARUK

My research was funded previously by a Fellowship from the Alzheimer’s Society, current funding is from a Senior Fellowship awarded by Alzheimer’s Research UK.

Collaborations

Selected Publications

Sigfridsson E, Marangoni M, Johnson JA, Hardingham GE, Fowler JH*, Horsburgh K* (2018) Astrocyte-specific overexpression of Nrf2 protects against optic tract damage and behavioural alterations in a mouse model of cerebral hypoperfusion. Sci Rep. 2018 Aug 22;8(1):12552. doi: 10.1038/s41598-018-30675-4 * Equal contribution

Horsburgh K, Wardlaw JM, van Agtmael T, Allan SM, Ashford MLJ, Bath PM, Brown R, Berwick J, Cader MZ, Carare RO, Davis JB, Duncombe J, Farr TD, Fowler JH, Goense J, Granata A, Hall CN, Hainsworth AH, Harvey A, Hawkes CA, Joutel A, Kalaria RN, Kehoe PG, Lawrence CB, Lockhart A, Love S, Macleod MR, Macrae IM, Markus HS, McCabe C, McColl BW, Meakin PJ, Miller A, Nedergaard M, O'Sullivan M, Quinn TJ, Rajani R, Saksida LM, Smith C, Smith KJ, Touyz RM, Trueman RC, Wang T, Williams A, Williams SCR, Work LM (2018) Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology. Clin Sci (Lond). 2018 Apr 30;132(8):851-868. doi: 10.1042/CS20171620. Print 2018 Apr 30. Review.

Fowler JH, McQueen J, Holland PR, Manso Y, Marangoni M, Scott F, Chisholm E, Scannevin RH, Hardingham GE, Horsburgh K (2017) Dimethyl fumarate improves white matter function following severe hypoperfusion: Involvement of microglia/macrophages and inflammatory mediators.  J Cereb Blood Flow Metab 271678X17713105. doi: 10.1177/0271678X17713105. [Epub ahead of print] 

McQueen J, Reimer MM, Holland PR, Manso Y, McLaughlin M, Fowler JH, Horsburgh K (2014) Restoration of oligodendrocyte pools in a mouse model of chronic cerebral hypoperfusion. PLoS One Feb 3;9(2):e87227. doi: 10.1371/journal.pone.0087227. eCollection 2014 

Martel MA, Ryan TJ*, Bell KF*, Fowler JH*, McMahon A, Al-Mubarak B, Komiyama NH, Horsburgh K, Kind PC, Grant SG, Wyllie DJ, Hardingham GE (2012) The Subtype of GluN2 C-terminal Domain Determines the Response to Excitotoxic Insults.  Neuron. 2012 74(3):543-56. (* Equal contribution)

Horsburgh K, Reimer MM,  Holland P, Chen G, Scullion G, Fowler JH (2011) Axon-glial disruption- the link between vascular disease and Alzheimer’s disease? Biochemical  Society Transactions, 39(4):881-5.

Bell KFS, Fowler JH, Al-Mubarak B, Horsburgh K and Hardingham GE (2011) Activation of Nrf2-regulated glutathione pathway genes by ischemic preconditioning.  Oxidative Medicine and Cellular Longevity, doi: 10.1155/2011/689524. Epub 2011 Jun 28.

Bell KFS, Al-Mubarak B, Fowler JH, Baxter PS, Tsujita T, Chowdhry S, Horsburgh K, Hayes JD and Hardingham GE (2011) Mild oxidative stress activates Nrf2 in astrocytes which contributes to neuroprotective ischemic preconditioning. Proceedings of the National Academy of Sciences  108(1)E1-2

Spain A, Daumas S, Lifshitz J, Rhodes J, Andrews PA, Horsburgh K, Fowler JH (2010) Mild fluid percussion injury in mice produces evolving selective axonal pathology and cognitive deficits relevant to human brain injury.  Journal of Neurotrauma 27(8):1429-38

Key Earlier Publications

Coltman R*, Spain A*, Tsenkina Y*, Fowler JH, Smith J, Scullion G, Allerhand M, Scott F, Kalaria RN, Ihara M, Daumas S, Deary IJ, Wood E, McCulloch J, Horsburgh K (2010) Spatial memory remains intact despite widespread white matter pathology.  In press Neurobiology of Aging.  * Joint first authors.

Papadia S, Soriano FX, Léveillé F, Martel MA, Dakin KA, Hansen HH, Kaindl A, Sifringer M, Fowler J, Stefovska V, McKenzie G, Craigon M, Corriveau R, Ghazal P, Horsburgh K, Yankner BA, Wyllie DJ, Ikonomidou C, Hardingham GE (2008)  Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses.  Nature Neuroscience, 11(4):476-87.

Fowler JH, Edgar JE, McCulloch J, McLaughlin M, Griffiths I.R, Garbern J, Nave K-A, Dewar D (2006) alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid-mediated excitotoxic axonal damage is attenuated in the absence of myelin proteolipid protein.   Journal of Neuroscience Research, 84(1):68-77.

Fowler JH, Whalley K, Murray TK, Ward MA, O’Neill MJ and McCulloch J (2004) The AMPA receptor potentiator LY404187 increases cerebral glucose utilization and c-fos expression in the rat.  Journal of Cerebral Blood Flow and Metabolism 24(10)1098-1109.

Fowler JH, McCracken E, McCulloch J, Dewar D (2003) Intracerebral injection of AMPA causes axonal damage in vivo.  Brain Research  991(1-2):104-12.